Vera Therapeutics, Inc.
Ticker: 1831828
P/L Snapshot
Q3 FY26 · consolidated
Revenue
10.28
Expenditure
105.98
Net Profit
-93.71
OPM %
-100.00%
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingVERA
20269Jul
Board Meeting
Chief Regulatory Officer Transition — William Turner to reti…
SEC Filing ↗ Board MeetingVERA
202621May
Board Meeting
2026 Annual Meeting of Stockholders to elect Class II Direct…
SEC Filing ↗